title: Dynamic prediction of metastases after radical prostatectomy for prostate cancer.
abstract: What's known on the subject? and What does the study add? One of two problems plagues virtually are existing post-prostatectomy prediction tools: either (1) they predict PSA recurrences (which are of unclear importance) or (2) the predictions they make are anchored at the date of surgery and are not updated based on how patients evolve over the postoperative years. Our prediction tool is a significant improvement over existing prediction tools in that it predicts the development of metastases which is a very important clinical endpoint that indicates incurable prostate cancer. Additionally, our tool allows for updated predictions at any point following radical prostatectomy by considering commonly available postoperative information (postoperative serum PSA and use of adjuvant therapies) to modify its risk predictions. The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course.
  
  
  OBJECTIVE
  • To develop a dynamic algorithm that predicts the risk of metastases from any time point after radical prostatectomy (RP).
  
  
  METHODS
  • The study cohort consisted of 5741 RP patients who were treated from 1990-99. • Patients were grouped into one of four clinical states at follow-up: State(1) , prostate-specific antigen (PSA) undetectable; State(2), PSA 0.15-0.39 ng/mL; State(3), PSA ≥0.4 ng/mL; and State(4), previous androgen deprivation or radiation therapy. • Follow-up epochs (alive and at risk of systemic progression) at 0, 2, 4 and 6 years post-RP, cumulative incidence curves and multistate Cox models were used to assess the risk of metastases over the ensuing 5-year interval. • Gleason score, seminal vesicle and surgical margin involvement, and PSA variables were evaluated as predictors.
  
  
  RESULTS
  • Median follow-up was 11.7 years, with 4411, 4256 and 3983 patients followed with PSA at 2, 4 and 6 years, respectively. • In total, 287 metastatic events occurred and the 5-year risk of metastasis was 0.4%, 2.1%, 8.7% and 12.6% for men in States 1, 2, 3 and 4, respectively. • Independent predictors of metastasis by group included seminal vesicle involvement (all groups), Gleason score (groups 1, 3 and 4), current PSA (groups 3 and 4) and maximum past PSA (group 4).
  
  
  CONCLUSIONS
  • We present a web-based prognostic tool for patients undergoing RP that is valid at many time points after surgery. • Our tool predicts the development of metastases.
authors: Division of Urology, Duke University Medical Center, Durham, NC, USA.
authors: Brant A
authors: BA
authors: Inman
authors: Igor
authors: I
authors: Frank
authors: Stephen A
authors: SA
authors: Boorjian
authors: Joseph W
authors: JW
authors: Akornor
authors: R Jeffrey
authors: RJ
authors: Karnes
authors: Bradley C
authors: BC
authors: Leibovich
authors: Michael L
authors: ML
authors: Blute
authors: Eric J
authors: EJ
authors: Bergstralh
references: J Clin Oncol. 1999 May;17(5):1499-507
references: 10334537
references: J Urol. 2005 Jun;173(6):1938-42
references: 15879786
references: J Urol. 2001 Apr;165(4):1146-51
references: 11257657
references: N Engl J Med. 1998 Oct 8;339(15):1036-42
references: 9761805
references: J Clin Oncol. 2005 Oct 1;23(28):7005-12
references: 16192588
references: J Urol. 2001 Jan;165(1):119-25
references: 11125379
references: J Urol. 1995 Jul;154(1):131-8
references: 7539857
references: N Engl J Med. 2004 Oct 7;351(15):1502-12
references: 15470213
references: J Urol. 2000 Jul;164(1):101-5
references: 10840432
references: J Clin Oncol. 2006 Aug 20;24(24):3973-8
references: 16921049
references: J Urol. 2001 Oct;166(4):1322-7
references: 11547066
references: J Urol. 1998 Mar;159(3):929-33
references: 9474185
references: Eur Urol. 2008 Jan;53(1):6-9
references: 17764823